triamcinolone acetonide has been researched along with Acute Myelogenous Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iacobelli, S; Longo, P; Mastrangelo, R; Ranelletti, FO; Riccardi, R | 1 |
| Beutler, E; Fairbanks, VF; Shanbrom, E; Steinfeld, JL | 1 |
2 other study(ies) available for triamcinolone acetonide and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Discrepancies between in vivo and in vitro effects of glucorticoids in myelomonocytic leukemic cells with steroid receptors.
Topics: Binding, Competitive; DNA, Neoplasm; Glucocorticoids; Humans; In Vitro Techniques; Infant; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Receptors, Glucocorticoid; Receptors, Steroid; RNA, Neoplasm; Steroids; Triamcinolone Acetonide | 1978 |
Prolonged remissions in acute myelocytic leukemia in adults.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Age Factors; Alkylating Agents; Colchicine; Female; Follow-Up Studies; Glucocorticoids; Humans; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Methylprednisolone; Middle Aged; Prednisone; Prognosis; Spironolactone; Triamcinolone Acetonide; Triazines; Uracil | 1968 |